According to Heineken, Ozempic could also change drinking habits

Heineken warns UK pubs to adapt to changing consumer habits due to the rise of weight-loss drugs like Ozempic and Wegovy, which reduce appetite and alcohol cravings. Research shows households using these medications spend significantly less on alcohol, particularly beer. Heineken suggests offering smaller, low-alcohol, and non-alcoholic options to cater to this trend, as users still consume alcohol but in moderation. The stakes are high, with UK pubs selling nearly £14 billion worth of beer annually, while low-alcohol and non-alcoholic sales remain below £300 million.